These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 22314881)

  • 1. Radical prostatectomy as primary treatment of high-risk prostate cancer.
    Ingels A; de la Taille A; Ploussard G
    Curr Urol Rep; 2012 Apr; 13(2):179-86. PubMed ID: 22314881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of radical prostatectomy versus external beam radiotherapy (75.6 Gy) combined with hormone therapy for prostate cancer of intermediate D'Amico risk classification].
    Boissier R; Karsenty G; Muracciole X; Daniel L; Delaporte V; Maurin C; Coulange C; Lechevallier E
    Prog Urol; 2013 Sep; 23(10):861-8. PubMed ID: 24034798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant hormone therapy after radiation or surgery for localized or locally advanced prostate cancer.
    See WA
    Curr Treat Options Oncol; 2003 Oct; 4(5):351-62. PubMed ID: 12941195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study.
    Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A
    BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term utility of adjuvant hormonal and radiation therapy for patients with seminal vesicle invasion at radical prostatectomy.
    Moschini M; Sharma V; Gandaglia G; Dell'Oglio P; Fossati N; Zaffuto E; Montorsi F; Briganti A; Karnes RJ
    BJU Int; 2017 Jul; 120(1):69-75. PubMed ID: 27753192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter phase II study of combined neoadjuvant docetaxel and hormone therapy before radical prostatectomy for patients with high risk localized prostate cancer.
    Chi KN; Chin JL; Winquist E; Klotz L; Saad F; Gleave ME
    J Urol; 2008 Aug; 180(2):565-70; discussion 570. PubMed ID: 18554663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodal treatment strategies combining neoadjuvant hormonal therapy and/or chemotherapy with radical prostatectomy in high-risk localised prostate cancer.
    Eastham JA
    Expert Opin Investig Drugs; 2004 Jan; 13(1):39-46. PubMed ID: 14680451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate cancer update.
    Rosenberg J; Small EJ
    Curr Opin Oncol; 2003 May; 15(3):217-21. PubMed ID: 12778015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of patients with prostate cancer and pathologic seminal vesicle invasion (pT3b): effect of adjuvant radiotherapy.
    Lee HM; Solan MJ; Lupinacci P; Gomella LG; Valicenti RK
    Urology; 2004 Jul; 64(1):84-9. PubMed ID: 15245941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing surgical treatment for prostate cancer.
    Gomella LG; Zeltser I; Valicenti RK
    Urology; 2003 Dec; 62 Suppl 1():46-54. PubMed ID: 14747041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-risk localized prostate cancer: primary surgery and adjuvant therapy.
    Skinner EC; Glode LM
    Urol Oncol; 2003; 21(3):219-27. PubMed ID: 12810210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial.
    Denham JW; Steigler A; Lamb DS; Joseph D; Turner S; Matthews J; Atkinson C; North J; Christie D; Spry NA; Tai KH; Wynne C; D'Este C
    Lancet Oncol; 2011 May; 12(5):451-9. PubMed ID: 21440505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term oncological outcome and risk stratification in men with high-risk prostate cancer treated with radical prostatectomy.
    Yamamoto S; Kawakami S; Yonese J; Fujii Y; Urakami S; Masuda H; Numao N; Ishikawa Y; Kohno A; Fukui I
    Jpn J Clin Oncol; 2012 Jun; 42(6):541-7. PubMed ID: 22457326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic overview of radiation therapy effects in prostate cancer.
    Nilsson S; Norlén BJ; Widmark A
    Acta Oncol; 2004; 43(4):316-81. PubMed ID: 15303499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of pelvic lymph node irradiation in salvage therapy for patients with prostate cancer with a biochemical relapse following radical prostatectomy.
    Kim BS; Lashkari A; Vongtama R; Lee SP; Parker RG
    Clin Prostate Cancer; 2004 Sep; 3(2):93-7. PubMed ID: 15479492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant Approaches Prior To Radical Prostatectomy.
    Ryan ST; Patel DN; Parsons JK; McKay RR
    Cancer J; 2020; 26(1):2-12. PubMed ID: 31977379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.
    Fujita N; Koie T; Ohyama C; Tanaka Y; Soma O; Matsumoto T; Yamamoto H; Imai A; Tobisawa Y; Yoneyama T; Hatakeyama S; Hashimoto Y
    Int J Clin Oncol; 2017 Dec; 22(6):1087-1093. PubMed ID: 28681153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological Outcomes After Radical Prostatectomy for High-Risk Prostate Cancer Based on New Gleason Grouping System: A Validation Study From University of Southern California With 3,755 Cases.
    Djaladat H; Amini E; Xu W; Cai J; Daneshmand S; Lieskovsky G
    Prostate; 2017 May; 77(7):743-748. PubMed ID: 28144967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.